60 results
Page 2 of 3
424B5
ttk3ay
4 Feb 19
Prospectus supplement for primary offering
5:52pm
6-K
EX-10.3
uvbzm9ab4ucd8
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
F-3/A
ym1upl7r
16 Oct 15
Shelf registration (foreign) (amended)
12:00am
20-F/A
EX-4.39
zd5025b37kec6kql3
22 Sep 15
Annual report (foreign) (amended)
12:00am
424B3
EX-1
3gb9d zsq6
8 Jun 15
Prospectus supplement
12:00am
20-F/A
ds3al1xmc8ws wt3c
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
EX-4.39
yf78vnd6g3p mdj
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B5
pt5mxwn4pu62
6 Mar 15
Prospectus supplement for primary offering
12:00am
424B5
aaonouvt
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
pqll 4744wv
5 Mar 15
Current report (foreign)
12:00am
424B2
yy4c05wc
13 Jun 14
Prospectus for primary offering
12:00am
F-3
dtgsqq7k7kvlk04q 54
30 May 14
Shelf registration (foreign)
12:00am
6-K
EX-1.1
9nx1y9jagyzcv9cjzdg
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am
424B5
t6hc4fdvaqa 8z
4 Mar 14
Prospectus supplement for primary offering
12:00am